WallStSmart

Gen Digital Inc. (GEN)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Gen Digital Inc. generates 1726% more annual revenue ($4.73B vs $258.90M). GEN leads profitability with a 12.8% profit margin vs -15.5%. GEN earns a higher WallStSmart Score of 76/100 (B+).

GEN

Strong Buy

76

out of 100

Grade: B+

Growth: 8.0Profit: 8.0Value: 6.7Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

GENOvervalued (-10.4%)

Margin of Safety

-10.4%

Fair Value

$22.34

Current Price

$19.14

$3.20 premium

UndervaluedFair: $22.34Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GEN5 strengths · Avg: 9.0/10
PEG RatioValuation
0.4710/10

Growing faster than its price suggests

Operating MarginProfitability
35.8%10/10

Strong operational efficiency at 35.8%

Return on EquityProfitability
26.9%9/10

Every $100 of equity generates 27 in profit

Revenue GrowthGrowth
25.8%8/10

Revenue surging 25.8% year-over-year

EPS GrowthGrowth
20.1%8/10

Earnings expanding 20.1% YoY

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

GEN0 concerns · Avg: 0/10

No major concerns identified

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : GEN

The strongest argument for GEN centers on PEG Ratio, Operating Margin, Return on Equity. Revenue growth of 25.8% demonstrates continued momentum. PEG of 0.47 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : GEN

No major red flags identified for GEN, but monitor valuation.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

GEN profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

GEN scores higher overall (76/100 vs 41/100) and 25.8% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Gen Digital Inc.

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Gen Digital Inc. provides cybersecurity solutions for consumers in the United States, Canada, Latin America, Europe, the Middle East, Africa, Asia Pacific, and Japan. The company is headquartered in Tempe, Arizona.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?